[go: up one dir, main page]

Follow
Fiona McCartney
Title
Cited by
Cited by
Year
Safety concerns over the use of intestinal permeation enhancers: A mini-review
F McCartney, JP Gleeson, DJ Brayden
Tissue barriers 4 (2), e1176822, 2016
1732016
Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: ex vivo and in vivo rat studies
F McCartney, V Jannin, S Chevrier, H Boulghobra, DR Hristov, N Ritter, ...
Journal of Controlled Release 310, 115-126, 2019
1212019
Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin
E Presas, F McCartney, E Sultan, C Hunger, S Nellen, CV Alvarez, ...
Journal of controlled release 286, 402-414, 2018
602018
Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae
S Maher, J Heade, F McCartney, S Waters, SB Bleiel, DJ Brayden
International journal of pharmaceutics 539 (1-2), 11-22, 2018
582018
Evaluation of sucrose laurate as an intestinal permeation enhancer for macromolecules: ex vivo and in vivo studies
F McCartney, M Rosa, DJ Brayden
Pharmaceutics 11 (11), 565, 2019
532019
Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease
N Shrestha, Y Xu, JRC Prévost, F McCartney, D Brayden, R Frédérick, ...
Acta biomaterialia 140, 561-572, 2022
502022
Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C10): Isolated rat intestinal mucosae and sacs
C Twarog, F McCartney, SM Harrison, B Illel, E Fattal, DJ Brayden
European Journal of Pharmaceutical Sciences 158, 105685, 2021
452021
Silica-Coated Nanoparticles with a Core of Zinc, l-Arginine, and a Peptide Designed for Oral Delivery
D Hristov, F McCartney, J Beirne, E Mahon, S Reid, S Bhattacharjee, ...
ACS Applied Materials & Interfaces 12 (1), 1257-1269, 2019
362019
Striving towards the perfect in vitro oral drug absorption model
JP Gleeson, F McCartney
Trends in pharmacological sciences 40 (10), 720-724, 2019
252019
Challenges in permeability assessment for oral drug product development
M Koziolek, P Augustijns, C Berger, R Cristofoletti, D Dahlgren, J Keemink, ...
Pharmaceutics 15 (10), 2397, 2023
242023
An enteric-coated polyelectrolyte nanocomplex delivers insulin in rat intestinal instillations when combined with a permeation enhancer
S Sladek, F McCartney, M Eskander, DJ Dunne, MJ Santos-Martinez, ...
Pharmaceutics 12 (3), 259, 2020
222020
Barriers to the intestinal absorption of four insulin-loaded arginine-rich nanoparticles in human and rat
P Lundquist, G Khodus, Z Niu, LN Thwala, F McCartney, I Simoff, ...
ACS nano 16 (9), 14210-14229, 2022
182022
Permeability-enhancing effects of three laurate-disaccharide monoesters across isolated rat intestinal mucosae
F McCartney, DR Perinelli, M Tiboni, R Cavanagh, S Lucarini, GF Palmieri, ...
International Journal of Pharmaceutics 601, 120593, 2021
152021
Synthesis and in vivo evaluation of insulin-loaded whey beads as an oral peptide delivery system
J Heade, F McCartney, M Chenlo, OM Marro, M Severic, R Kent, SB Bleiel, ...
Pharmaceutics 13 (5), 656, 2021
92021
Safety concerns over the use of intestinal permeation enhancers: a mini-review. Tissue Barriers. 2016; 4 (2): e1176822
F McCartney, JP Gleeson, DJ Brayden
9
An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragment to treat inflammatory bowel disease
W Zhang, F McCartney, Y Xu, CB Michalowski, I Domingues, EK Kambale, ...
Journal of Controlled Release 374, 254-266, 2024
82024
The UCD nanosafety workshop (03 December 2018): towards developing a consensus on safe handling of nanomaterials within the Irish university labs and beyond–a report
V Stuttgen, HE Giffney, A Anandan, A Alabdali, C Twarog, SA Belhout, ...
Nanotoxicology 13 (6), 717-732, 2019
82019
Cystic ovary disease impairs transport speed, smooth muscle contraction, and epithelial ion transport in the bovine oviduct
DM Scully, D Campion, F McCartney, K Dulohery, S Reese, S Kölle
Molecular Reproduction and Development 88 (8), 558-570, 2021
62021
Solidified ionic liquid-based formulations of metformin with enhanced GI epithelial permeability
E Tsolaki, F McCartney, AM Healy, DJ Brayden, S Ferguson
International Journal of Pharmaceutics, 125649, 2025
42025
LabrafacTM MC60 is an efficacious intestinal permeation enhancer for macromolecules: Comparisons with Labrasol® ALF in ex vivo and in vivo rat studies
F Mccartney, P Caisse, C Dumont, DJ Brayden
International Journal of Pharmaceutics 661, 124353, 2024
42024
The system can't perform the operation now. Try again later.
Articles 1–20